Prednisone

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prednisone

Prednisone: What It Is

Property Description
Active ingredient Prednisone (Prodrug)
Form Tablet, Oral Solution, Syrup
Pharmacological class Glucocorticoid (Corticosteroid)
General purpose Anti-inflammatory and Immunosuppressive
Origin Synthetic Compound

Prednisone: Defining the Drug and Its Origin

Prednisone is a powerful synthetic drug classified as a glucocorticoid, a potent type of corticosteroid that mimics the actions of hormones naturally produced by the body's adrenal glands. This means the medication is designed to interact with the body's hormonal systems to regulate functions. Its status as a widely used systemic agent is clinically recognized by major health organizations for its profound impact on systemic biological processes. Prednisone is available exclusively as a prescription-only medication.


Composition: Prednisone as a Prodrug

The chemical entity administered orally is Prednisone, which operates as a prodrug derived from precursor compounds like Prednisolone Acetate. This compound is biologically inactive upon consumption and must first undergo a necessary transformation—specifically hepatic conversion in the liver—to become its true, pharmacologically active form, Prednisolone. The drug is readily absorbed via the oral route, with common dosage forms including the solid tablet and the liquid oral solution or syrup, a feature that allows for its precise administration across different patient groups.


The General Purpose of This Systemic Medication

The essential general purpose of Prednisone is to exert potent anti-inflammatory and immunosuppressive effects. Glucocorticoids, including Prednisone, act by modulating the body's inflammatory response and immune function. This capability makes it critical for general scenarios involving the rapid and sustained attenuation of widespread inflammation, such as managing acute flares of systemic autoimmune conditions. By mimicking endogenous corticosteroids, the drug helps to regulate various systemic functions, providing widespread relief.

Regulatory References

  1. Prednisone - StatPearls - NCBI Bookshelf

What side effects are possible with Prednisone?

Possible Side Effects and Safety Information

The safety profile of Prednisone, a systemic glucocorticoid, is officially documented by health authorities and involves a range of potential effects across multiple physiological systems. Adverse reactions are grouped by the affected System-Organ Class (SOC) and often relate to the medicine's widespread impact on hormonal and metabolic processes.

Common and System-Based Adverse Reactions

Adverse reactions classified as common in regulatory documents often include fluid retention, elevated blood pressure, increased appetite leading to weight gain, and changes in glucose tolerance. The official safety listing encompasses effects across various systems:

  • Metabolism and Nutrition: Potential for electrolyte imbalances, such as potassium loss.
  • Endocrine: Development of a Cushingoid state and suppression of the body's natural corticosteroid production.
  • Psychiatric: Reports of insomnia, mood swings, and other behavioral changes.
  • Musculoskeletal: Risks to bone health, including osteoporosis and muscle weakness (myopathy).

Serious Reactions and Duration-Related Safety Patterns

Official labels document serious adverse reactions such as peptic ulceration with potential for hemorrhage or perforation, aseptic necrosis of bone, and posterior subcapsular cataracts. Many clinically significant risks, including the development of a Cushingoid state and severe osteoporosis, are formally associated with long-term use.

A specific safety constraint highlighted in regulatory sources is the risk of adrenocortical insufficiency upon the cessation of therapy, particularly following prolonged use. Furthermore, Prednisone is contraindicated in patients with active systemic fungal infections.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes the overdose profile for Prednisone primarily in the context of chronic exposure to high doses, rather than specific acute toxic events. Acute overdose is generally not expected to produce life-threatening symptoms, according to government labeling.

Documented Manifestations and Actions

Focus Area Official Regulatory Statement
Chronic Manifestations Clinical signs often reflect the effects of long-term, high-dose exposure, including the development of a Cushingoid state, thinning skin, and easy bruising [NIH DailyMed].
Acute Toxic Effects High doses may be associated with neuropsychiatric reactions such as insomnia, delusions, hallucinations, and psychosis [SmPC Context].
Emergency Actions Required Seek immediate emergency medical attention upon suspected overdose. Regulators mandate contacting a Poisons Information Centre or Poison Help line immediately [DailyMed/Regulatory Context].
Management Treatment consists of symptomatic and supportive therapy, as no specific antidote is documented in the prescribing information [SmPC Context].

Official Guidance on When to Seek Urgent Help

Urgent medical help must be sought immediately following any suspected overdose, irrespective of acute symptom severity. This immediate action is mandated due to the potential for serious reactions and the requirement for professional, supportive monitoring. Special consideration is noted for the elderly, where consequences from common side effects of high-dose corticosteroids may be more serious.

Therapeutic Uses of Prednisone

Prednisone: Main Uses and Benefits

Treatment of Acute Systemic Inflammation and Autoimmune Flares

The medication is commonly used across conditions presenting with acute or disruptive episodes where symptoms may intensify temporarily. Its therapeutic purpose is recognized across numerous clinical settings. Prednisone is used to help with symptoms related to physical discomfort, such as intense pain and stiffness, associated with chronic conditions like Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Inflammatory Bowel Disease (IBD). It may provide support that helps patients cope more steadily with difficult episodes of disease intensification, assisting with managing symptoms that create noticeable physiological strain.


Stabilization of Severe Allergic and Supportive Uses

It is also applied when managing conditions such as severe allergic reactions, asthma exacerbations, and certain dermatologic and ocular inflammations. The drug is applied across domains where additional symptomatic support is needed. It is used in managing the body's immune response to a transplanted organ and assists with maintaining functional stability for individuals with adrenocortical insufficiency. This supportive use helps maintain a sense of stability when symptoms are more noticeable and assists with managing symptoms that interfere with daily functioning.


Quick Fact: Support for Symptom Management Prednisone is generally used when symptoms related to inflammatory or irritative states become highly disruptive, providing support that helps ease the overall symptom burden.

Regulatory References

  1. Label: PREDNISONE tablet - DailyMed

Eligibility and Restrictions for Use

Official Prednisone Population Eligibility

The eligibility profile for Prednisone is strictly defined by regulatory documents, which list absolute contraindications and mandatory restrictions based on patient population and pre-existing conditions.

Contraindicated Populations

Prednisone must not be used in patients with systemic fungal infections or a documented hypersensitivity to the medication or its components. It is also contraindicated for patients receiving immunosuppressive doses who are scheduled to receive live or live-attenuated vaccines.

Restricted or Conditional Use

Use requires caution or is restricted in several populations as specified in labeling:

Population Group Regulatory Restriction
Infectious Status Contraindicated unless systemic infections are simultaneously treated. Latent parasitic diseases (e.g., Strongyloides) must be ruled out.
Organ Function Caution required in hepatic impairment (cirrhosis) and renal impairment due to altered drug clearance.
Age Groups Long-term use in the pediatric population requires close monitoring of growth and development due to potential suppression.
Reproductive Status Pregnancy (especially first trimester) carries risks of fetal harm. The drug is excreted into human milk during lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Prednisone interacts with several medicinal product categories, primarily through metabolic changes and pharmacodynamic effects, as documented in official regulatory labeling.


Metabolically-Driven Interactions (CYP3A4)

Interacting Product Category Effect on Prednisone/Corticosteroid
Hepatic Enzyme Inducers (e.g., Rifampin, Phenytoin) May decrease corticosteroid plasma concentrations by enhancing metabolism.
Hepatic Enzyme Inhibitors (e.g., Ketoconazole, Macrolide Antibiotics) May increase corticosteroid plasma concentrations by inhibiting metabolism.

Prednisone itself is a moderate inducer of Cytochrome P450 3A4 (CYP3A4) and may consequently increase the clearance of certain co-administered drugs metabolized by this enzyme (e.g., Indinavir, Erythromycin), leading to decreased effectiveness of those medications.


Pharmacodynamic and Safety-Related Interactions

Interacting Product Category Interaction Context
Potassium-Depleting Agents (e.g., Diuretics, Amphotericin B) Increased risk of hypokalemia (low potassium).
Oral Anticoagulants (e.g., Warfarin) Requires frequent monitoring of coagulation indices, as effects can be variable.
Anticholinesterase Agents (e.g., Neostigmine) Use in patients with myasthenia gravis may cause severe weakness; withdrawal of the agent may be required before starting prednisone.
Antidiabetics May increase blood glucose concentrations, requiring adjustments in antidiabetic dosage.
Live or Live-Attenuated Vaccines Administration is generally not recommended due to potential for reduced vaccine effectiveness or increased risk of infection.

Corticosteroids may also increase the risk of tendon rupture when co-administered with Fluoroquinolones (e.g., Ciprofloxacin, Levofloxacin), particularly in the elderly. The drug Mifepristone is restricted from co-administration as it can counteract the effects of prednisone.

Mechanism of Action

Prednisone is a synthetic glucocorticoid. After conversion to prednisolone, it works by entering the cell and binding to the cytosolic glucocorticoid receptor (GR). This receptor-ligand complex then translocates to the nucleus, where it binds to specific DNA sequences (glucocorticoid response elements, or GREs) to modulate gene transcription. This mechanism, known as transactivation, upregulates the expression of anti-inflammatory proteins, such as lipocortin-1 (annexin A1). Concurrently, the complex can interact with and suppress other transcription factors (e.g., NF-boldsymbolkappaB and AP-1) via protein-protein interactions, a process known as transrepression. This transrepression reduces the expression of pro-inflammatory mediators, including various cytokines (e.g., IL-6, TNF-alpha) and chemokines. The resulting change in gene expression reduces the activity of phospholipase A2 and cyclooxygenase (COX-2), and inhibits capillary permeability. Furthermore, the drug modulates osteoclast differentiation and activity.

Dosage and Administration Information

Prednisone is officially administered only via the oral route, available as immediate-release tablets, liquid solutions, and delayed-release tablets. The initial daily dose is highly variable, ranging from 5 mg to 60 mg, and is gradually adjusted to the lowest effective maintenance level, often between 5 mg and 20 mg daily. Dosing is prescribed as either a single daily dose, often administered in the morning, or as divided doses throughout the day. For long-term use, a specific regimen known as Alternate Day Therapy (ADT) involves taking a double dose every other morning.

The medication is instructed to be taken with food or milk to help reduce gastrointestinal irritation. Liquid forms must be accurately measured using a calibrated device, and delayed-release tablets must be swallowed whole, as they should not be crushed or chewed. Pediatric dosing is guided by disease severity and is often calculated based on body weight.

Dosage may require a temporary increase during periods of significant physiological stress, such as severe illness or surgery. Following prolonged therapy, the medication must be discontinued using a gradual dosage reduction (tapering) schedule, not abrupt cessation. If a dose is missed, it should be taken as soon as remembered, unless it is close to the next scheduled dose, in which case the missed dose must be skipped—doses are not to be doubled.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Prednisone

The evidence surrounding Prednisone describes research for conditions associated with inflammatory or irritative states and systemic immune activity. Research in this area is complex, relying on trials and long-term observational studies that examine how symptoms change over time across different patient populations. The information below summarizes the types of studies conducted and what aspects of the condition they explored.


Evidence for Use in Chronic Systemic Inflammatory Conditions

Research for conditions like Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) was conducted using short-term to medium-term Randomized Controlled Trials (RCTs) and large observational cohort studies. Researchers examined outcomes related to physical discomfort, standardized measures of disease activity, and, for RA, measures of joint damage progression using X-rays.

Studies reported measurements where outcomes related to systemic or functional imbalance were registered during the defined study periods. The evidence often explores the drug when it is used in combination with other prescription medications, which means the research is contextualized by a multi-drug regimen.


Evidence for Managing Acute Flares and Exacerbations

For Inflammatory Bowel Disease (IBD), research primarily includes short-term RCTs that focus on episodes where symptoms become more noticeable. These studies was studied for their potential to achieve clinical remission, meaning a reduction in outcomes linked to inflammatory or irritative states. Findings described patterns observed in the studies where a measured change in acute symptom burden was recorded during the initial treatment interval. Research for Acute Asthma Exacerbations also involves short-term RCTs, focusing on the resolution of acute symptoms and examining outcomes reflecting daily functioning or activity level and measures of pulmonary function (such as Peak Flow readings).


Key Uncertainties and Research Gaps

Despite the breadth of research, several key uncertainties and gaps remain in the evidence landscape. For many chronic conditions, the drug is used in combination with other therapies, meaning comparative evidence is lacking to fully isolate its effects. Furthermore, long-term effects are not fully established by continuous, large-scale RCTs, and data for certain groups remain insufficient, particularly concerning the long-term impact on specific special populations. The consistency of findings evidence quality varies across studies and the study results reflect the specific conditions under which they were conducted.

Key Studies & References

  1. Prednisone tablet (DailyMed FDA Label)
  2. Oral Dexamethasone vs. Oral Prednisone for Children With Acute Asthma Exacerbations: A Systematic Review and Meta-Analysis
  3. Effects of prednisolone tapering on effectiveness of infliximab in patients with ulcerative colitis: data from a retrospective

Frequently Asked Questions (FAQ)

Common questions about Prednisone (FAQ)

Q: What is the difference between Prednisone and Prednisolone?

According to official product information, Prednisone is known as a prodrug, meaning it is inactive when swallowed. It must be converted by the liver into its active form, prednisolone, before it can have its therapeutic effects on the body.

Q: How quickly does Prednisone usually start to reduce symptoms?

Studies indicate that the medication usually starts to act quickly after an oral dose. Effects often begin within one to two hours after taking the tablet or solution, which is when the active form enters your system.

Q: How long does the effect of one dose of Prednisone typically last?

Regulatory information indicates that the biological effects of a single dose generally last for an extended period, typically between 12 and 36 hours.

Q: What are the most commonly reported side effects in patient discussions?

The officially documented common side effects of this medication are often discussed by patients. These include fluid retention, elevated blood pressure, increased appetite leading to weight gain, and changes in mood or sleep patterns.

Q: Why might Prednisone cause a feeling of anxiety or 'jitters'?

The official documentation lists psychiatric adverse reactions as a potential effect. These reactions can include feeling anxious, restlessness, and general changes in mood.

Q: Are the side effects of Prednisone permanent after stopping use?

Most temporary side effects, such as increased appetite and water retention, typically resolve after the medication is discontinued and the body readjusts. However, certain long-term risks such as cataracts or severe osteoporosis may persist.

Q: Can Prednisone cause stomach upset or digestive issues?

Official safety information states the medication is often instructed to be taken with food or milk, as this may help to minimize gastrointestinal irritation and stomach problems.

Q: Are there any common foods or supplements that are described as interacting with Prednisone?

Caution is generally advised regarding the consumption of liquorice, as it may increase the drug's effect and raise the risk of low potassium levels. Furthermore, regulatory guidelines advise that dietary sodium restriction and potassium supplementation may be necessary during prolonged therapy.

Q: Is it safe to take Prednisone with common over-the-counter pain relievers?

Official warnings specifically advise caution when combining this medication with NSAIDs (non-steroidal anti-inflammatory drugs), such as ibuprofen, naproxen, or aspirin. This combination carries an increased risk of gastrointestinal side effects, including ulcers and bleeding.

Q: Is Prednisone available in different tablet strengths?

Yes, regulatory documents confirm that prednisone tablets are available in multiple strengths to allow for the prescribed dosage flexibility. These strengths may include, but are not limited to, 2.5 mg, 5 mg, 10 mg, 20 mg, and 50 mg.

Q: What is the meaning of 'tapering' when talking about Prednisone?

Tapering is the necessary process of gradually reducing the dosage over a period of time, rather than stopping abruptly. This process is required in order to allow the body's adrenal glands to resume their natural function and prevent symptoms of withdrawal or a condition called adrenocortical insufficiency.

Q: Are there official warnings about combining Prednisone with alcohol?

Official warnings indicate that while there is no universally listed direct drug interaction, combining the two may increase the risk and severity of shared side effects. These shared effects include stomach upset, high blood pressure, and immune suppression.

Q: Is Prednisone considered a medication that carries a risk of dependence or addiction?

Official documents do not typically associate this medication with drug-seeking behavior (addiction). However, the body can develop a physical reliance (dependence) over time due to the suppression of natural hormone production. This is why a tapering process is required when stopping the medication.

Q: What is the usual duration of a course of Prednisone?

The official product information describes that the duration of treatment is variable based on the condition. For many acute conditions, the initial suppressive dose is kept as brief as possible, typically around 4 to 10 days before beginning the required taper.

Q: Does Prednisone commonly cause a person to bruise more easily?

Yes, easy bruising, along with skin thinning and fragility, are listed in official product documentation as potential side effects of the medication.

Q: Are there different brand names used for the drug Prednisone?

Yes, Prednisone is the generic name for the active ingredient. It is also sold under various brand names, such as Deltasone and Rayos, depending on the specific product formulation.

How should Prednisone be stored and disposed of?

How to Store and Dispose of Prednisone

Prednisone tablets require storage at Controlled Room Temperature, which is maintained between 20 C and 25 C (68 F and 77 F). The medication must be protected from moisture and kept in the container it was dispensed in, secured with a tightly closed container.

Official Protection and Disposal Rules

To ensure safety, prednisone must be stored out of the sight and reach of children. The product must not be used past the expiration date stated on the packaging.

Disposal of unused or expired prednisone must be handled according to local regulations. The official guidance advises against disposal by flushing down a toilet or pouring into a drain, or placing in household trash, unless a local drug take-back program specifically instructs otherwise. Consult a pharmacist or local waste company for proper procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prednisone found in:

A-Z Index: